Fathom, a leading developer of autonomous medical coding technology, has secured a strategic investment from CVS Health Ventures. This move highlights the increasing demand for top-quality AI systems that can significantly improve various aspects of RCM among healthcare providers and payers.
This strategic decision is well-timed as it coincides with a transformative phase for the adoption of AI in healthcare financial operations. More and more, organizations are focusing on technology investments that not only align with their operational goals but also offer a measurable return. In fact, industry research including a study by Bain & Company with KLAS Research identifies revenue cycle management as a key area where health IT expenditure is expected to increase. What is more, healthcare leaders continue to acknowledge the significant financial and operational benefits brought about by autonomous coding solutions.
“Fathom is already delivering real, measurable ROI at a time when the entire ecosystem is facing significant cost pressures,” said Carter Prince, Partner, CVS Health Ventures. “We believe Fathom’s accuracy has potential to become a trusted, consistent, and neutral representation of the care delivered, creating new opportunities to reimagine and strengthen payer-provider relationships.”
Also Read: HB Wealth Expands Arch Partnership to Scale Private Markets Operations and Reporting
A key differentiator for Fathom lies in its multi-specialty deployment model, enabling healthcare systems to implement autonomous coding across departments simultaneously. This eliminates the inefficiencies associated with traditional, phased AI rollouts and significantly reduces IT resource strain. As a result, organizations benefit from faster implementation timelines, improved coding accuracy, and immediate financial impact.
“CFOs and revenue cycle leaders across the country are demanding real ROI stories from AI, and autonomous coding is delivering,” said Andrew Lockhart, CEO of Fathom. “By increasing efficiency through higher coding accuracy and consistency, we are not only improving patient and provider experience of care, we’re proving that AI can be a true catalyst for financial performance at enterprise scale. This investment from CVS Health Ventures supports the momentum we’re seeing and accelerates our ability to serve the growing demand from providers and health plans nationwide.”
As the strongest player in the market, Fathom was also recognized as the one who most effectively reduced the cost of care in the 2025 Emerging Solutions Top 20 Report by KLAS Research, getting a 95.5/100 performance score in the first time autonomous coding evaluation. Prior results from a 2024 spotlight report also showed that customers were very satisfied, with users reporting automation rates of more than 90% and high accuracy.
Thanks to the recently raised capital, Fathom is now ready to enhance the pace of the development and broaden the reach of its AI-driven coding platform that supports healthcare organizations in revenue cycle modernization, financial viability improvement, and care delivery transformation.
